{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:25:57Z","timestamp":1792301157038,"version":"4.4.0"},"reference-count":64,"publisher":"Endocrinology Research Centre","issue":"4","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>Polycystic Ovary Syndrome (PCOS) \u2014 is a polygenic endocrine disorder caused by genetic, hormonal, and epigenetic factors. The importance of addressing PCOS lies in its prevalence, affecting approximately 10 to 13% of women, as well as the associated health conditions that can have a negative impact on women\u2019s lives, including infertility, dermatological manifestations of hyperandrogenism (such as hirsutism and acne), cardiovascular pathologies, metabolic disorders, and psychoemotional disorders. Currently, many theories of the development of this disease have been proposed, and as a consequence of methods of influencing and treating it. According to the clinical recommendations of the Ministry of Health of the Russian Federation, modifying the patient\u2019s lifestyle forms the basis of comprehensive therapy. We have analyzed about 60 articles on various dietary approaches to the treatment of PCOS, sourced from PubMed, Nature Reviews, Oxford Academic, Clinical Nutrition, EJOG, ScienceDirect, and MDPI. The Mediterranean diet, the DASH diet, the ketogenic diet and the low-carb diet have proven themselves the best. Also, it\u2019s necessary to add vitamin D, E, folic acid, calcium, various pro- and prebiotics to a woman\u2019s diet. Currently, the use of inositol and GPP-1 is becoming a promising method of PCOS therapy. According to the results of the analysis, a positive effect of diet therapy on the anthropometric and biochemical parameters was noted. Based on the analysis, a positive effect of diet therapy on anthropometric and biochemical parameters has been observed. It is crucial to consider the individual characteristics of each patient and not rely solely on drug therapy when approaching the treatment of PCOS.<\/jats:p>","DOI":"10.14341\/probl13400","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:42:57Z","timestamp":1726591377000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":5,"title":["Polycystic ovary syndrome: new and promising treatment methods"],"prefix":"10.14341","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0751-8749","authenticated-orcid":true,"given":"D. M.","family":"Gasieva","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-0254","authenticated-orcid":true,"given":"E. V.","family":"Sheremetyeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-2576","authenticated-orcid":true,"given":"M. F.","family":"Kalashnikova","sequence":"additional","affiliation":[{"name":"N.V. Sklifosovskiy Institute of Clinical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-9063","authenticated-orcid":true,"given":"F. Kh.","family":"Dzgoeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2086-2167","authenticated-orcid":true,"given":"E. T.","family":"Alborova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5458","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"ref1","unstructured":"\u0421\u0438\u043d\u0434\u0440\u043e\u043c \u043f\u043e\u043b\u0438\u043a\u0438\u0441\u0442\u043e\u0437\u043d\u044b\u0445 \u044f\u0438\u0447\u043d\u0438\u043a\u043e\u0432: \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u041c\u0417 \u0420\u0424. \u2014 \u041c\u043e\u0441\u043a\u0432\u0430, 2023; 61 \u0441. https:\/\/www.endocrincentr.ru\/sites\/default\/files\/specialists\/science\/clinic-recomendations\/kr258_sindrom_polikistoznyh_yaichnikov.pdf?ysclid=lk45nttt4v463388066"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fauser BCJM, Tarlatzis, Fauser, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47. doi: https:\/\/doi.org\/10.1093\/humrep\/deh098","DOI":"10.1093\/humrep\/deh098"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, et al. International PCOS Network. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;15:463. doi: https:\/\/doi.org\/10.1210\/clinem\/dgad463","DOI":"10.1210\/clinem\/dgad463"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. https:\/\/www.nature.com\/articles\/nrdp201657","DOI":"10.1038\/nrdp.2016.57"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic Aspects of the Polycystic Ovary Syndrome. Endocr Rev. 2012;33(5):812-841. doi: https:\/\/doi.org\/10.1210\/er.2012-1003","DOI":"10.1210\/er.2012-1003"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites. 2021;11(12):869. doi: https:\/\/doi.org\/10.3390\/metabo11120869","DOI":"10.3390\/metabo11120869"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016;37(5):467-520. doi: https:\/\/doi.org\/10.1210\/er.2015-1104","DOI":"10.1210\/er.2015-1104"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Zeng X, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0009898119321187","DOI":"10.1016\/j.cca.2019.11.003"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017;88(6):371-395. doi: https:\/\/doi.org\/10.1159\/000479371","DOI":"10.1159\/000479371"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sadeghi HM, Adeli I, Calina D, et al. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022. doi: https:\/\/doi.org\/10.3390\/ijms23020583","DOI":"10.3390\/ijms23020583"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ranjbaran J, Farimani M, Tavilani H, et al. Matrix metalloproteinases 2 and 9 and MMP9\/NGAL complex activity in women with PCOS. Reproduction. 2016. doi: https:\/\/doi.org\/10.1530\/REP-15-0340","DOI":"10.1530\/REP-15-0340"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Xiao S, Li Y, Li T, et al. Evidence for Decreased Expression of ADAMTS-1 Associated With Impaired Oocyte Quality in PCOS Patients. J Clin Endocrinol Metab. 2014;99(6):E1015-E1021. doi: https:\/\/doi.org\/10.1210\/jc.2013-4177","DOI":"10.1210\/jc.2013-4177"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-379. doi: https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.004","DOI":"10.1111\/cen.13795"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Zhang X, Zheng Y, Guo Y, Lai Z. The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol. 2019;2019:1-14. doi: https:\/\/doi.org\/10.1155\/2019\/4386401","DOI":"10.1155\/2019\/4386401"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104. doi: https:\/\/doi.org\/10.1186\/s12967-020-02277-0","DOI":"10.1186\/s12967-020-02277-0"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019;11(10):2278. doi: https:\/\/doi.org\/10.3390\/nu11102278","DOI":"10.3390\/nu11102278"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Foroozanfard F, Rafiei H, Samimi M, et al. The effects of dietary approaches to stop hypertension diet on weight loss, anti\u2010M\u00fcllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clin Endocrinol (Oxf). 2017;87(1):51-58. doi: https:\/\/doi.org\/10.1111\/cen.13333","DOI":"10.1111\/cen.13333"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Che X, Chen Z, Liu M, Mo Z. Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome. Ann Nutr Metab. 2021;77(6):313-323. doi: https:\/\/doi.org\/10.1159\/000519302","DOI":"10.1159\/000519302"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Liang Z, Di N, Li L, Yang D. Gut microbiota alterations reveal potential gut\u2013brain axis changes in polycystic ovary syndrome. J Endocrinol Invest. 2021;44(8):1727-1737. doi: https:\/\/doi.org\/10.1007\/s40618-020-01481-5","DOI":"10.1007\/s40618-020-01481-5"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"N.I. Ursova. Solving the problem of altered microbiocenosis in children with irritable bowel syndrome. Farmateka. 2019;26(2):70-76 (In Russ.).] doi: https:\/\/dx.doi.org\/10.18565\/pharmateca.2019.1.70-76","DOI":"10.18565\/pharmateca.2019.1.70-76"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Torres PJ, Siakowska M, Banaszewska B, et al. Gut Microbial Diversity in Women with Polycystic Ovary Syndrome Correlates with Hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502-11. doi: https:\/\/doi.org\/10.1210\/jc.2017-02153","DOI":"10.1210\/jc.2017-02153"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study. PLoS One. 2017. doi: https:\/\/doi.org\/10.1371\/journal.pone.0168390","DOI":"10.1371\/journal.pone.0168390"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wie\u00ebrs G, Belkhir L, Enaud R, et al. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2020;9. doi: https:\/\/doi.org\/10.3389\/fcimb.2019.00454","DOI":"10.3389\/fcimb.2019.00454"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Li Y, Tan Y, Xia G, Shuai J. Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2023;63(4):522-538. doi: https:\/\/doi.org\/10.1080\/10408398.2021.1951155","DOI":"10.1080\/10408398.2021.1951155"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018. doi: https:\/\/doi.org\/10.1186\/s13048-018-0457-1","DOI":"10.1186\/s13048-018-0457-1"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Abboud M, Rizk R, AlAnouti F, Papandreou D, Haidar S, Mahboub N. The Health Effects of Vitamin D and Probiotic Co-Supplementation: A Systematic Review of Randomized Controlled Trials. Nutrients. 2020;13(1):111. doi: https:\/\/doi.org\/10.3390\/nu13010111","DOI":"10.3390\/nu13010111"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Shoaei T, Heidari-Beni M, Tehrani H, Feizi A, Esmaillzadeh A, Askari G. Effects of probiotic supplementation on pancreatic \u03b2-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Int J Prev Med. 2015;6(1):27. doi: https:\/\/doi.org\/10.4103\/2008-7802.153866","DOI":"10.4103\/2008-7802.153866"},{"key":"ref28","unstructured":"Karamali M, Eghbalpour S, Rajabi S, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2018. http:\/\/journalaim.com\/Article\/aim-1912"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Zhang J, Sun Z, Jiang S, et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis \/\/ JASM (American society of microbiology). 2019;4(2):17-19. doi: https:\/\/doi.org\/10.1128\/msystems.00017-19","DOI":"10.1128\/mSystems.00017-19"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bindels LB, Delzenne NM, Cani PD, Walter J. Opinion: Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015. doi: https:\/\/doi.org\/10.1038\/nrgastro.2015.47","DOI":"10.1038\/nrgastro.2015.47"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019. doi: https:\/\/doi.org\/10.1007\/s00394-018-1648-7","DOI":"10.1007\/s00394-018-1648-7"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Newgard CB. Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin Resistance. Cell Metab. 2012;15(5):606-614. doi: https:\/\/doi.org\/10.1016\/j.cmet.2012.01.024","DOI":"10.1016\/j.cmet.2012.01.024"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Lumme J, Sebert S, Pesonen P, et al. Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study. Nutrients. 2019;11(11):2831. doi: https:\/\/doi.org\/10.3390\/nu11112831","DOI":"10.3390\/nu11112831"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Krul-Poel YHM, Koenders PP, Steegers-Theunissen RP, et al. Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study. Narayanan R, ed. PLoS One. 2018;13(12):e0204748. doi: https:\/\/doi.org\/10.1371\/journal.pone.0204748","DOI":"10.1371\/journal.pone.0204748"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"He C, Lin Z, Robb S, Ezeamama A. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2015;7(6):4555-4577. doi: https:\/\/doi.org\/10.3390\/nu7064555","DOI":"10.3390\/nu7064555"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Zhao J, Liu S, Wang Y, et al. Vitamin D improves in-vitro fertilization outcomes in infertile women with polycystic ovary syndrome and insulin resistance. Minerva Med. 2019;110(3). doi: https:\/\/doi.org\/10.23736\/S0026-4806.18.05946-3","DOI":"10.23736\/S0026-4806.18.05946-3"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Kuyucu Y, \u00c7elik LS, Kendirlinan \u00d6, Tap \u00d6, Mete U\u00d6. Investigation of the uterine structural changes in the experimental model with polycystic ovary syndrome and effects of vitamin D treatment: An ultrastructural and immunohistochemical study. Reprod Biol. 2018;18(1):53-59. doi: https:\/\/doi.org\/10.1016\/j.repbio.2018.01.002","DOI":"10.1016\/j.repbio.2018.01.002"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Guo S, Tal R, Jiang H, Yuan T, Liu Y. Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A SystematicReview of RCTs and Insight into the Underlying Mechanism. Int J Endocrinol. 2020. doi: https:\/\/doi.org\/10.1155\/2020\/7850816","DOI":"10.1155\/2020\/7850816"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Miao C, Fang X, Chen Y, Zhang Q. Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis. Exp Ther Med. February 2020. doi: https:\/\/doi.org\/10.3892\/etm.2020.8525","DOI":"10.3892\/etm.2020.8525"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Al-Bayyari N, Al-Domi H, Zayed F, Hailat R, Eaton A. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial. Clin Nutr. 2021;40(3):870-878. doi: https:\/\/doi.org\/10.1016\/j.clnu.2020.09.024","DOI":"10.1016\/j.clnu.2020.09.024"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ullah G, Jung P, Machaca K. Modeling Ca2+ signaling differentiation during oocyte maturation. Cell Calcium. 2007. doi: https:\/\/doi.org\/10.1016\/j.ceca.2007.01.010","DOI":"10.1016\/j.ceca.2007.01.010"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Firouzabadi R dehghani, Aflatoonian A, Modarresi S, Sekhavat L, MohammadTaheri S. Therapeutic effects of calcium &amp; vitamin D supplementation in women with PCOS. Complement Ther Clin Pract. 2012;18(2):85-88. doi: https:\/\/doi.org\/10.1016\/j.ctcp.2012.01.005","DOI":"10.1016\/j.ctcp.2012.01.005"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Bizzarri M, Monti N, Piombarolo A, Angeloni A, Verna R. Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. Nutrients. 2023. doi: https:\/\/doi.org\/10.3390\/nu15081875","DOI":"10.3390\/nu15081875"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Dinicola S., Unfer V., Facchinetti F. \u0438 \u0434\u0440. \u0418\u043d\u043e\u0437\u0438\u0442\u043e\u043b: \u043e\u0442 \u043d\u0430\u043a\u043e\u043f\u043b\u0435\u043d\u043d\u044b\u0445 \u0437\u043d\u0430\u043d\u0438\u0439 \u043a \u043d\u043e\u0432\u0430\u0446\u0438\u044f\u043c (\u043f\u0435\u0440. \u041e.\u0410 \u041f\u0443\u0441\u0442\u043e\u0442\u0438\u043d\u043e\u0439). \u042d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2022; 18 (7): 20\u201342. doi: https:\/\/doi.org\/10.33978\/2307-3586-2022-18-7-20-42","DOI":"10.12968\/S0261-2097(22)60010-8"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Tagliaferri V, Romualdi D, Immediata V, et al. Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study. Clin Endocrinol (Oxf). 2017. doi: https:\/\/doi.org\/10.1111\/cen.13304","DOI":"10.1111\/cen.13304"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Emek\u00e7i \u00d6zay \u00d6, \u00d6zay AC, \u00c7a\u011fl\u0131yan E, Okyay RE, G\u00fclekli B. Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. Gynecol Endocrinol. 2017. doi: https:\/\/doi.org\/10.1080\/09513590.2017.1296127","DOI":"10.1080\/09513590.2017.1296127"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. Int J Endocrinol. 2016. doi: https:\/\/doi.org\/10.1155\/2016\/3204083","DOI":"10.1155\/2016\/3204083"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Lagan\u00e0 AS, Rossetti P, Buscema M, et al. Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols. Int J Endocrinol. 2016. doi: https:\/\/doi.org\/10.1155\/2016\/6306410","DOI":"10.1155\/2016\/6306410"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2017;33(1):39-42. doi: https:\/\/doi.org\/10.1080\/09513590.2016.1236078","DOI":"10.1080\/09513590.2016.1236078"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Unfer V, Facchinetti F, Orr\u00f9 B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. doi: https:\/\/doi.org\/10.1530\/EC-17-0243","DOI":"10.1530\/EC-17-0243"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. Int J Endocrinol. 2016. doi: https:\/\/doi.org\/10.1155\/2016\/3204083","DOI":"10.1155\/2016\/3204083"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Szczuko M, Hawry\u0142kowicz V, Kikut J, Drozd A. The implications of vitamin content in the plasma in reference to the parameters of carbohydrate metabolism and hormone and lipid profiles in PCOS. J Steroid Biochem Mol Biol. 2020;198:105570. doi: https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105570","DOI":"10.1016\/j.jsbmb.2019.105570"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Badawy A, State O, El Gawad SSA, El Aziz OA. Plasma homocysteine and polycystic ovary syndrome: The missed link. Eur J Obstet Gynecol Reprod Biol. 2007;131(1):68-72. doi: https:\/\/doi.org\/10.1016\/j.ejogrb.2006.10.015","DOI":"10.1016\/j.ejogrb.2006.10.015"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Kaya C, Cengiz SD, Satiro\u011flu H. Obesity and insulin resistance associated with lower plasma vitamin B 12 in PCOS. Reprod Biomed Online. 2009. doi: https:\/\/doi.org\/10.1016\/j.rbmo.2009.06.005","DOI":"10.1016\/j.rbmo.2009.06.005"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Kilicdag EB, Bagis T, Tarim E, et al. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod. 2005;20(6):1521-1528. doi: https:\/\/doi.org\/10.1093\/humrep\/deh825","DOI":"10.1093\/humrep\/deh825"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Lind MV, Lauritzen L, Kristensen M, Ross AB, Eriksen JN. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019;109(1):29-42. doi: https:\/\/doi.org\/10.1093\/ajcn\/nqy234","DOI":"10.1093\/ajcn\/nqy234"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Jafari A, Gholizadeh E, Sadrmanesh O, et al. The effect of folic acid supplementation on body weight and body mass index: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2023. doi: https:\/\/doi.org\/10.1016\/j.clnesp.2022.11.020","DOI":"10.1016\/j.clnesp.2022.11.020"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Yalle-V\u00e1squez S, Osco-Rosales K, Nieto-Gutierrez W, Benites-Zapata V, P\u00e9rez-L\u00f3pez FR, Alarcon-Ruiz CA. Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2022. doi: https:\/\/doi.org\/10.1080\/09513590.2022.2079629","DOI":"10.1080\/09513590.2022.2079629"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Heidari H, Hajhashemy Z, Saneei P. A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome. Sci Rep. 2022;12(1):19927. doi: https:\/\/doi.org\/10.1038\/s41598-022-24467-0","DOI":"10.1038\/s41598-022-24467-0"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017. doi: https:\/\/doi.org\/10.1016\/j.mce.2016.09.008","DOI":"10.1016\/j.mce.2016.09.008"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018;27(4):740-756. doi: https:\/\/doi.org\/10.1016\/j.cmet.2018.03.001","DOI":"10.1016\/j.cmet.2018.03.001"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Han Y, Li Y, He B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39(2):332-342. doi: https:\/\/doi.org\/10.1016\/j.rbmo.2019.04.017","DOI":"10.1016\/j.rbmo.2019.04.017"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Salamun V, Jensterle M, Janez A, Bokal EV. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol. 2018. doi: https:\/\/doi.org\/10.1530\/EJE-18-0175","DOI":"10.1530\/EJE-18-0175"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang Y, Zheng SY, et al. Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017. doi: https:\/\/doi.org\/10.1111\/cen.13454","DOI":"10.1111\/cen.13454"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13400\/10713","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:43:37Z","timestamp":1726591417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,16]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13400","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"value":"2308-1430","type":"electronic"},{"value":"0375-9660","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}